DK331287D0 - Praeparater til hindring af transplantationsudstoedelse - Google Patents

Praeparater til hindring af transplantationsudstoedelse

Info

Publication number
DK331287D0
DK331287D0 DK331287A DK331287A DK331287D0 DK 331287 D0 DK331287 D0 DK 331287D0 DK 331287 A DK331287 A DK 331287A DK 331287 A DK331287 A DK 331287A DK 331287 D0 DK331287 D0 DK 331287D0
Authority
DK
Denmark
Prior art keywords
heparin
preparations
humans
preventing transplant
per cent
Prior art date
Application number
DK331287A
Other languages
English (en)
Other versions
DK169422B1 (da
DK331287A (da
Inventor
Irun Cohen
Israel Vlodavsky
Amiram Eldor
Yaakov Naparstek
Original Assignee
Yeda Res & Dev
Hadassah Mid Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Hadassah Mid Org filed Critical Yeda Res & Dev
Publication of DK331287D0 publication Critical patent/DK331287D0/da
Publication of DK331287A publication Critical patent/DK331287A/da
Application granted granted Critical
Publication of DK169422B1 publication Critical patent/DK169422B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Soil Working Implements (AREA)
  • Paper (AREA)
  • Fertilizers (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK331287A 1986-06-26 1987-06-26 Anvendelse af heparin, N-desulfateret, N-acetyleret heparin eller O-desulfateret, N-acetyleret heparin til fremstilling af et farmaceutisk præparat, som er effektivt over for autoimmune sygdomme, til lindring af sådanne sygdomme og til behandling af autoimmune sygdomme i pattedyr, herunder mennesker, og til hindring eller forsinkelse af allotransplantatudstødelse DK169422B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL7925486 1986-06-26
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Publications (3)

Publication Number Publication Date
DK331287D0 true DK331287D0 (da) 1987-06-26
DK331287A DK331287A (da) 1987-12-27
DK169422B1 DK169422B1 (da) 1994-10-31

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK331287A DK169422B1 (da) 1986-06-26 1987-06-26 Anvendelse af heparin, N-desulfateret, N-acetyleret heparin eller O-desulfateret, N-acetyleret heparin til fremstilling af et farmaceutisk præparat, som er effektivt over for autoimmune sygdomme, til lindring af sådanne sygdomme og til behandling af autoimmune sygdomme i pattedyr, herunder mennesker, og til hindring eller forsinkelse af allotransplantatudstødelse

Country Status (10)

Country Link
EP (1) EP0251134B1 (da)
JP (1) JP2527749B2 (da)
AT (1) ATE82502T1 (da)
AU (1) AU608228B2 (da)
DE (1) DE3782686T2 (da)
DK (1) DK169422B1 (da)
ES (1) ES2052514T3 (da)
GR (1) GR3006814T3 (da)
IL (1) IL79254A0 (da)
NO (1) NO872675L (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
DE69835016T2 (de) * 1997-07-14 2007-06-28 Muramatsu, Takashi, Nagoya Verwendung von midkin oder von anti-midkin antikörper
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N-位脱硫酸肝素在预防和治疗炎症中的应用
MXPA04002217A (es) 2001-09-12 2004-07-08 Sigma Tau Ind Farmaceuti Derivados de glucosaminoglucanas parcialmente desulfatados como inhibidores de heparanasa, dotados con actividad antiangiogenica y libres de efectos anticoagulantes.
EP1748781B1 (en) 2004-05-27 2012-12-19 Baxter International Inc. Methods for treating bleeding disorders using sulfated polysaccharides
EP2326334A2 (en) 2008-08-22 2011-06-01 Baxter Healthcare SA Methods for treating bleeding disorders
AU2011205271B2 (en) 2010-01-14 2014-01-30 Baxalta GmbH Methods and compositions for treating bleeding disorders
WO2013012954A2 (en) 2011-07-19 2013-01-24 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
EP2885642B1 (en) 2012-08-14 2019-05-15 Baxalta GmbH Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
US9265791B2 (en) 2013-03-12 2016-02-23 Baxalta GmbH Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
CN108367023B (zh) * 2015-06-11 2021-04-20 马斯特里赫特大学 预防宿主中移植物衰竭的方法

Also Published As

Publication number Publication date
DE3782686T2 (de) 1993-06-09
JPS6388127A (ja) 1988-04-19
JP2527749B2 (ja) 1996-08-28
ATE82502T1 (de) 1992-12-15
NO872675D0 (no) 1987-06-25
GR3006814T3 (da) 1993-06-30
ES2052514T3 (es) 1994-07-16
DK169422B1 (da) 1994-10-31
AU608228B2 (en) 1991-03-28
EP0251134B1 (en) 1992-11-19
IL79254A0 (en) 1986-09-30
EP0251134A3 (en) 1989-05-03
DE3782686D1 (de) 1992-12-24
AU7470687A (en) 1988-01-07
EP0251134A2 (en) 1988-01-07
NO872675L (no) 1987-12-28
DK331287A (da) 1987-12-27

Similar Documents

Publication Publication Date Title
DK331287A (da) Praeparater til hindring af transplantationsudstoedelse
DE3587266D1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
DK602387A (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
TNSN87021A1 (fr) Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
ES2099158T3 (es) Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
FI923476A0 (fi) Kvaevederivat.
ES2152998T3 (es) Agente anticomplementario obtenido a partir de fucanos de algas pardas.
DE68913075T2 (de) Stabilisiertes Arzneimittel und Verfahren zu dessen Herstellung.
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
EP0011651A4 (en) Pharmaceutical preparation containing 3-oxo-2,3-dihydro (1) -benzothiophene-2-spirocyclopropane and this compound for use in the prophylaxis or treatment of caridovascular disorders.
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
ES2070116T3 (es) Peptidos que inhiben la union del factor von willebrand.
DK0506658T3 (da) Sammensætninger og fremgangsmåde til behandling af smertefulde, inflammatoriske eller allergiske lidelser
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE3854121T2 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
ES2099865T3 (es) Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares.
DE3751362T2 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
WO1992004359A3 (en) Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
ATE114457T1 (de) Kosmetische zusammensetzung auf der basis von pflanzenextrakten.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
SE8303886D0 (sv) Synergetisk antihypertensiv farmaceutisk komposition
DK0391224T3 (da) Lægemiddel og anvendelse heraf til behandling af parasitoser

Legal Events

Date Code Title Description
A0 Application filed
B1 Patent granted (law 1993)
PBP Patent lapsed